|
Symbol
|
RMA93V | RMBA5V | RMBAQV | RMALEV | CIEBKB | RMBRQV | PEZRCH | ABKBTQ | Z0AASZ | RMA6EV | RMAWAV | PJPRCH | RMADDV | RMAVUV | RMA03V | PODRCH | PQFRCH | RMBNYV | RMBT8V | PTYRCH |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible |
|
Sous-jacent
|
Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG / Straumann Hldg. AG | Alcon / Lonza Group N / Novartis AG / Sandoz Group AG | Alcon / Nestlé S.A. / Novartis AG / Roche PS / Sandoz Group AG | Alcon / Givaudan / Lonza Group N / Sandoz Group AG | Alcon / Galderma Group AG / Novartis AG / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Alcon / Sandoz Group AG / Straumann Hldg. AG | Aryzta AG / Compagnie Financière Richemont SA / Sandoz Group AG | Alcon / Sandoz Group AG / Sonova Hldg. AG / VAT Group | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Sandoz Group AG / Sika AG / UBS Group AG | Alcon / Novartis AG / Sandoz | Alcon / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | Lonza Group N / Partners Group Hldg. AG / Sandoz Group AG / Swiss RE AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Holcim/Amrize Basket / Sandoz Group AG / Sika AG / Straumann Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
12.01.2027 | 05.01.2027 | 09.11.2026 | 15.03.2027 | 18.11.2026 | 22.11.2027 | 18.11.2026 | 12.11.2026 | 11.11.2026 | 07.12.2026 | 21.12.2026 | 23.12.2026 | 05.01.2027 | 21.12.2026 | 01.02.2027 | 03.02.2027 | 17.11.2026 | 08.03.2027 | 22.02.2027 | 10.03.2027 |
| Demande | 100,60 | 100,30 | - | 67,90 | 101,43 | 96,50 | 101,42 | 101,18 | - | 100,50 | 65,50 | 100,51 | 100,40 | 81,10 | 76,60 | 96,41 | 101,57 | 53,20 | 99,70 | 99,54 |
| Offre | 101,60 | 101,30 | - | - | 102,30 | 97,50 | - | 102,04 | - | 101,50 | - | - | 101,40 | - | - | - | 102,44 | - | 100,70 | - |